CYTHW
Cyclo Therapeutics Warrant (CYTHW)
$08
About Cyclo Therapeutics Warrant (CYTHW)
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
Details
Daily high
$0.08
Daily low
$0.08
Price at open
$0.08
52 Week High
$0.37
52 Week Low
$0.05
Market cap
--
Dividend yield
0.00%
Volume
10
Avg. volume
817
P/E ratio
--
Cyclo Therapeutics Warrant News
Details
Daily high
$0.08
Daily low
$0.08
Price at open
$0.08
52 Week High
$0.37
52 Week Low
$0.05
Market cap
--
Dividend yield
0.00%
Volume
10
Avg. volume
817
P/E ratio
--